BioIntelliSense Acquires AlertWatch Clinical Intelligence Engine

October 18, 2022

BioIntelliSense, a continuous health monitoring and clinical intelligence company, has acquired AlertWatch, an FDA-cleared clinical intelligence and triage system. The acquisition combines AlertWatch’s multi-parameter decision support and centralized triage dashboard with BioIntelliSense’s medical-grade BioButton wearable and DaaS platform, and AlertWatch will be distributed to U.S. hospitals through Medtronic’s Patient Monitoring business as part of BioIntelliSense’s HealthCast portfolio.

Buyers
BioIntelliSense, Inc.
Targets
AlertWatch
Location
Michigan, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.